Expert Review of Precision Medicine and Drug Development publishes primarily review articles covering the development and clinical application of medicine to be used in a personalized therapy setting; in addition, the journal also publishes original research and commentary-style articles. In an era where medicine is recognizing that a one-size-fits-all approach is not always appropriate, it has become necessary to identify patients responsive to treatments and treat patient populations using a tailored approach. Areas covered include: Development and application of drugs targeted to specific genotypes and populations, as well as advanced diagnostic technologies and significant biomarkers that aid in this. Clinical trials and case studies within personalized therapy and drug development. Screening, prediction and prevention of disease, prediction of adverse events, treatment monitoring, effects of metabolomics and microbiomics on treatment. Secondary population research, genome-wide association studies, disease–gene association studies, personal genome technologies. Ethical and cost–benefit issues, the impact to healthcare and business infrastructure, and regulatory issues.
CiteScore:
CiteScore
SJR
SNIP
CiteScore排名
2.3
0.257
0.144
学科
排名
百分位
大类:Pharmacology, Toxicology and Pharmaceutics 小类:Pharmacology
224 / 313
28%
大类:Pharmacology, Toxicology and Pharmaceutics 小类:Drug Discovery
119 / 157
24%
大类:Biochemistry, Genetics and Molecular Biology 小类:Genetics
278 / 347
20%
大类:Biochemistry, Genetics and Molecular Biology 小类:Molecular Medicine
Pub Date : 2024-03-18DOI: 10.1080/23808993.2024.2330422V. Mollica, M. Rosellini, Stefano Brocchi, Francesco Galuppi, A. Paccapelo, Valentina Tateo, Andrea Marchetti, Elisa Tassinari, Francesco Mantuano, M. Santoni, F. Massari